Who it's for: Patients wanting to understand genetic contributors to chronic illness, inflammation, methylation, detoxification capacity, or treatment response
Semaglutide, tirzepatide, and retatrutide (Biosynth, Compton, UK, lot #s 0000042482, 0000054911, and 0000205204 respectively) were dissolved in 0.3% phosphate-buffered saline (PBS), which was adjusted to a pH of 8.0 using NaOH and injected subcutaneously (s.c.) at 1 ml/kg
Medically reviewed by:Medura Clinical Team Last updated:July 21, 2026 Why patients choose Medura
The study was conducted in 19951996, and we used commercially available synthetic, human GLP-1 (736 amide) [6]
And remember: Avoid any telehealth company falsely claiming that compounded drugs have been approved by the FDA